Complete Filing Data
Biodexa Pharmaceuticals Plc reported Cash And Cash Equivalents of $8.53 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Biodexa Pharmaceuticals Plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $4.0M | $5.4M | $4.1M | $5.1M | $4.7M | $6.1M | $7.8M | $9.4M | $8.3M | $7.7M | $8.7M |
| Profit Loss From Operating Activities | -$8.6M | -$9.2M | -$8.0M | -$8.9M | -$7.0M | -$23.0M | -$11.3M | -$11.8M | -$13.3M | -$9.7M | -$12.9M |
| Profit Loss Before Tax | -$6.5M | -$6.0M | -$7.5M | -$8.5M | -$6.1M | -$23.5M | -$10.9M | -$12.4M | -$13.0M | -$8.4M | -$11.2M |
| Profit Loss | -$6.4M | -$5.7M | -$7.1M | -$7.7M | -$5.5M | -$22.2M | -$10.1M | -$15.0M | -$16.1M | -$20.2M | -$10.1M |
| Income Tax Expense Continuing Operations | -$105.0K | -$250.0K | -$406.0K | -$832.0K | -$646.0K | -$1.3M | $1.8M | -$2.0M | -$1.3M | -$2.2M | -$1.1M |
| Comprehensive Income Attributable To Owners Of Parent | -$6.4M | -$5.7M | -$7.1M | -$7.7M | -$5.5M | -$21.7M | -$10.3M | -$17.7M | -$17.3M | -$16.9M | -$9.7M |
| Adjustments For Reconcile Profit Loss | -$8.0M | -$8.7M | -$7.6M | -$8.2M | -$6.5M | -$9.7M | -$10.2M | -$13.4M | -$13.0M | -$14.6M | -$12.2M |
| Adjustments For Income Tax Expense | -$105.0K | -$250.0K | -$406.0K | -$832.0K | -$646.0K | -$1.3M | -$1.8M | -$2.0M | -$1.3M | -$9.2M | -$1.1M |
| Income Taxes Paid Refund Classified As Operating Activities | -$707.0K | -$129.0K | -$845.0K | -$678.0K | -$1.2M | -$2.0M | -$1.9M | -$1.4M | -$1.5M | -$1.7M | -$646.0K |
| Sales Revenue | $699.0K | $578.0K | $180.0K | $312.0K | $149.0K | $149.0K | $776.0K | $775.0K | |||
| Other Comprehensive Income | $3.0K | $508.0K | -$207.0K | -$2.7M | -$1.2M | $3.2M | $399.0K | ||||
| Revenue From Government Grants | $163.0K | $362.0K | $1.8M | $840.0K | $547.0K | $600.0K | |||||
| Profit Loss From Continuing Operations | -$5.5M | -$22.2M | -$9.1M | -$10.4M | -$11.7M | -$6.2M | |||||
| Profit Loss For Year | $22.2M | $10.1M | $15.0M | $16.1M | $20.2M | $10.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $8.5M | $1.7M | $6.0M | $2.8M | $10.1M | $7.5M | $10.9M | $2.3M | $13.2M | $17.6M | $16.2M | $30.3M |
| Current Derivative Financial Liabilities | $2.9M | $383.0K | $4.2M | $85.0K | $553.0K | $1.6M | $664.0K | $400.0K | $1.6M | |||
| Liabilities | $6.8M | $6.5M | $5.9M | $2.4M | $2.5M | $3.1M | $11.3M | $3.5M | $14.5M | $11.0M | $17.2M | |
| Changes In Equity | $9.5M | $9.4M | $8.6M | $366.0K | $9.2M | $8.8M | $12.9M | -$36.0K | $6.2M | $15.8M | $14.6M | |
| Cash Flows From Used In Operations | -$6.3M | -$12.4M | -$7.7M | -$7.7M | -$7.2M | -$11.3M | -$8.4M | -$14.8M | -$14.4M | -$14.7M | -$13.1M | |
| Cash Flows From Used In Operating Activities | -$5.6M | -$12.3M | -$6.8M | -$7.0M | -$6.0M | -$9.3M | -$6.5M | -$13.5M | -$13.0M | -$13.1M | -$12.4M | |
| Cash Flows From Used In Investing Activities | -$583.0K | -$598.0K | -$265.0K | -$220.0K | -$278.0K | $2.6M | -$3.8M | $9.0M | -$1.5M | -$1.2M | -$1.5M | |
| Cash Flows From Used In Financing Activities | $13.0M | $8.6M | $10.2M | $47.0K | $8.8M | $3.1M | $18.7M | -$6.5M | $10.3M | $15.3M | -$219.0K | |
| Property Plant And Equipment | $91.0K | $324.0K | $571.0K | $831.0K | $1.2M | $542.0K | $2.2M | $2.0M | $2.5M | $2.8M | $2.0M | $1.5M |
| Adjustments For Increase Decrease In Trade Account Payable | -$913.0K | $2.2M | -$207.0K | $356.0K | -$130.0K | -$2.0M | $1.1M | -$3.0M | -$267.0K | $358.0K | $711.0K | |
| Adjustments For Decrease Increase In Trade Account Receivable | $2.6M | -$6.0M | $365.0K | $7.0K | -$487.0K | $493.0K | $725.0K | $1.0M | -$968.0K | -$242.0K | -$1.5M | |
| Trade And Other Current Receivables | $3.8M | $6.6M | $637.0K | $1.0M | $1.0M | $572.0K | $992.0K | $1.3M | $3.2M | $2.4M | $2.5M | |
| Trade And Other Current Payables | $2.6M | $3.5M | $1.2M | $1.4M | $1.1M | $1.2M | $4.5M | $2.1M | $8.0M | $8.4M | $7.1M | |
| Retained Earnings | -$155.8M | -$150.4M | -$144.8M | -$135.3M | -$127.8M | -$122.4M | -$99.8M | -$89.7M | -$74.7M | -$59.1M | -$39.2M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $2.0K | $9.0K | $26.0K | $62.0K | $320.0K | $209.0K | $310.0K | $244.0K | $707.0K | $1.3M | $922.0K | |
| Noncurrent Liabilities | $645.0K | $1.4M | $295.0K | $463.0K | $620.0K | $110.0K | $5.7M | $1.0M | $6.2M | $1.6M | $8.1M | |
| Noncurrent Assets | $5.7M | $6.0M | $3.5M | $837.0K | $1.2M | $542.0K | $17.2M | $14.8M | $30.6M | $34.4M | $43.7M | |
| Equity And Liabilities | $18.2M | $14.8M | $10.5M | $5.5M | $12.9M | $9.8M | $30.9M | $20.4M | $49.2M | $56.7M | $64.0M | |
| Current Tax Assets Current | $123.0K | $573.0K | $422.0K | $846.0K | $670.0K | $1.2M | $1.8M | $2.0M | $1.2M | $1.4M | $1.2M | |
| Current Liabilities | $6.1M | $5.0M | $5.6M | $1.9M | $1.8M | $3.0M | $5.7M | $2.5M | $8.4M | $9.3M | $9.1M | |
| Current Assets | $12.4M | $8.8M | $7.0M | $4.7M | $11.8M | $9.3M | $13.7M | $5.6M | $18.6M | $22.3M | $20.3M | |
| Assets | $18.2M | $14.8M | $10.5M | $5.5M | $12.9M | $9.8M | $30.9M | $20.4M | $49.2M | $56.7M | $64.0M | |
| Depreciation Rightofuse Assets | $136.0K | $135.0K | $137.0K | $166.0K | $190.0K | $118.0K | $303.0K | |||||
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | -$29.0K | -$4.0K | -$2.0K | -$14.0K | $39.0K | $226.0K | -$165.0K | -$27.0K | ||||
| Intangible Assets And Goodwill | $5.6M | $5.6M | $2.9M | $6.0K | $12.4M | $12.4M | $27.6M | $27.6M | $41.3M | $13.1M | ||
| Basic Earnings Loss Per Instrument Participating Equity Instruments Other Than Ordinary Shares | -2.00 | -155.00 | -136.00 | -10.36 | -50.0K | |||||||
| Purchase Of Intangible Assets Classified As Investing Activities | $9.0K | $778.0K | $19.0K | $3.0K | ||||||||
| Other Noncurrent Receivables | $2.6M | $469.0K | $465.0K | $448.0K | $387.0K | |||||||
| Increase Decrease Through Change In Equity Of Share Issued2 | -$1.0M | -$489.0K | $6.2M | |||||||||
| Amounts Paid On Lease Liabilities | -$246.0K | -$186.0K | -$188.0K | -$178.0K | -$112.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | $6.9M | -$4.3M | $3.1M | -$7.2M | $2.5M | -$3.6M | $8.4M | -$10.9M | -$4.1M | $967.0K | -$14.2M |
| Proceeds From Issuing Shares | 13.7M | 8.3M | 10.4M | 243.0K | 9.0M | 9.7M | 14.1M | 5.7M | 15.6M | ||
| Payments Of Lease Liabilities Classified As Financing Activities | $178.0K | $112.0K | $258.0K | -$450.0K | $64.0K | $25.0K | |||||
| Proceeds From Disposal Of Fixed Assets | $18.0K | $4.0K | $20.0K | $42.0K | $143.0K | $25.0K | |||||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$8.0K | $261.0K | $148.0K | $19.0K | -$258.0K | $466.0K | $23.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $0.00 | $0.00 | $-0.02 | $-1.55 | |
| Basic Earnings Loss Per Share | $0.00 | $0.00 | $-0.02 | $-1.55 | |
| Shares Issued1 | 6.7M | 527.0K | 321.0K | 161.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease Through Sharebased Payment Transactions | $280.0K | $369.0K | $244.0K | $123.0K | $89.0K | -$404.0K | -$34.0K | -$36.0K | $520.0K | $203.0K | $170.0K |
| Finance Costs | $229.0K | $165.0K | $41.0K | $53.0K | $44.0K | $431.0K | $97.0K | $587.0K | $166.0K | $73.0K | $5.0K |
| Administrative Expense | $4.8M | $3.8M | $4.3M | $4.5M | $2.9M | $5.0M | $3.8M | $4.4M | $4.3M | $3.2M | $4.9M |
| Adjustments For Sharebased Payments | $170.0K | $283.0K | $28.0K | $123.0K | $89.0K | -$404.0K | -$34.0K | -$36.0K | $520.0K | $203.0K | $170.0K |
| Adjustments For Depreciation Expense | $52.0K | $117.0K | $143.0K | $174.0K | $213.0K | $1.1M | $979.0K | $1.0M | $983.0K | $772.0K | $501.0K |
| Finance Income | $2.4M | $3.4M | $570.0K | $497.0K | $936.0K | $1.0K | $492.0K | $2.0K | $415.0K | $1.3M | $1.7M |
| Share Premium | $98.9M | $93.1M | $86.7M | $83.7M | $83.4M | $74.4M | $65.9M | $52.9M | $52.9M | $47.2M | $31.6M |
| Merger Reserve | $53.0M | $53.0M | $53.0M | $53.0M | $53.0M | $53.0M | $53.0M | $53.0M | $53.0M | $53.0M | $52.8M |
| Issued Capital | $14.1M | $11.7M | $6.3M | $1.1M | $1.1M | $1.1M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M |
| Longterm Borrowings | $118.0K | $295.0K | $463.0K | $620.0K | $60.0K | $5.7M | $884.0K | $6.2M | $1.6M | $1.5M | |
| Interest Paid Classified As Financing Activities | $14.0K | $13.0K | $18.0K | $15.0K | $34.0K | $30.0K | $587.0K | $111.0K | $74.0K | $5.0K | |
| Interest Received Classified As Investing Activities | $90.0K | $176.0K | $73.0K | $29.0K | $1.0K | $8.0K | $2.0K | $15.0K | $164.0K | $53.0K | |
| Adjustments For Amortisation Expense | $1.0K | $2.0K | $3.0K | $3.0K | $10.0K | $3.0K | $434.0K | $1.6M | $3.6M | $236.0K | |
| Borrowings | $61.0K | $609.0K | $169.0K | $161.0K | $146.0K | $200.0K | $412.0K | ||||
| Warrant Reserve | $1.2M | $894.0K | $3.5M | $720.0K | $720.0K | $720.0K | |||||
| Other Income | $152.0K | $31.0K | $14.0K | $22.0K | $24.0K | $12.0K | $15.0K | ||||
| Adjustments For Provisions | -$207.0K | $157.0K | -$47.0K | -$68.0K | $165.0K | ||||||
| Gains Losses On Exchange Differences On Translation Net Of Tax | $508.0K | -$207.0K | $1.2M | -$1.2M | $3.2M | $399.0K | |||||
| Current Provisions | $207.0K | $50.0K | $97.0K | ||||||||
| Foreign Exchange Gainslosses | -$130.0K | $4.0K | -$1.0K | -$3.0K | $387.0K | ||||||
| Reserve Of Exchange Differences On Translation | -$508.0K | -$301.0K | $2.4M | $3.6M | $390.0K | ||||||
| Repayments Of Borrowings Classified As Financing Activities | $577.0K | $5.8M | $552.0K | $235.0K | $165.0K | ||||||
| Current Borrowings And Current Portion Of Noncurrent Borrowings | $200.0K | $412.0K | $368.0K | $361.0K | $538.0K | $442.0K | |||||
| Costs Associated With Share Issue1 | -$487.0K | -$441.0K | -$78.0K | -$10.0K | |||||||
| Costs Associated With Share Issue2 | -$352.0K | -$527.0K | -$78.0K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.